Caspary W F, Creutzfeldt W
Diabetologia. 1975 Apr;11(2):113-7. doi: 10.1007/BF00429833.
The effect of blood sugar lowering biguanides (phenethyl-, butyl- and dimethylbiguanide) upon jejunal and ileal transport of bile salts (tauro- and glycocholate) was tested in rat small intestine by an in vitro technique. Giguanides inhibited active transport of bile salts in the ileum, but did not affect diffusional absorption of bile salts in the jejunum. The inhibitory effect was time-dependent and not reversible under in vitro incubation conditions, suggesting that biguanides must enter intestinal mucosal cells in order to exert their inhibitory action on active transport of glucose analogues, amino acids, calcium and bile salts. Since biguanides achieve high tissue concentrations in the small intestine even after parenteral administration, inhibition of ileal bile salt reabsorption by biguanides could possibly explain the lipid- and cholesterol-lowering effect of these oral antidiabetic drugs.
采用体外技术,在大鼠小肠中测试了降血糖双胍类药物(苯乙双胍、丁双胍和二甲双胍)对空肠和回肠胆盐(牛磺胆酸盐和甘氨胆酸盐)转运的影响。双胍类药物抑制了回肠中胆盐的主动转运,但不影响空肠中胆盐的扩散吸收。这种抑制作用具有时间依赖性,并且在体外孵育条件下是不可逆的,这表明双胍类药物必须进入肠黏膜细胞才能对葡萄糖类似物、氨基酸、钙和胆盐的主动转运发挥抑制作用。由于即使经胃肠外给药后,双胍类药物在小肠中也能达到较高的组织浓度,因此双胍类药物对回肠胆盐重吸收的抑制作用可能解释了这些口服抗糖尿病药物的降血脂和降胆固醇作用。